About
Technology
Issues
FAQ
Links
Official Page
A RANDOMIZED PROSPECTIVE CONTROLLED TRIAL OF ORAL ACYCLOVIR VERSUS ORAL GANCICLOVIR FOR CYTOMEGALOVIRUS PROPHYLAXIS IN HIGH-RISK KIDNEY TRANSPLANT RECIPIENTS1
Distribution of the number of citations over years.
site/software ©
exaly
; All materials licenced under
CC by-SA
.